Prestige Consumer Healthcare (NYSE:PBH) Reaches New 12-Month Low – Here’s What Happened

Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) reached a new 52-week low on Friday . The company traded as low as $58.50 and last traded at $59.2730, with a volume of 45799 shares traded. The stock had previously closed at $59.99.

Analysts Set New Price Targets

Several research analysts have recently issued reports on PBH shares. Canaccord Genuity Group decreased their target price on Prestige Consumer Healthcare from $100.00 to $88.00 and set a “buy” rating for the company in a research report on Friday, November 7th. Sidoti raised Prestige Consumer Healthcare from a “neutral” rating to a “buy” rating and set a $80.00 price target on the stock in a research note on Wednesday, September 24th. Oppenheimer decreased their price objective on Prestige Consumer Healthcare from $82.00 to $72.00 and set an “outperform” rating for the company in a report on Tuesday, October 21st. Zacks Research upgraded shares of Prestige Consumer Healthcare from a “strong sell” rating to a “hold” rating in a report on Monday. Finally, Wall Street Zen downgraded shares of Prestige Consumer Healthcare from a “buy” rating to a “hold” rating in a research report on Saturday, August 9th. Four analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $85.33.

Prestige Consumer Healthcare Trading Down 1.0%

The stock’s 50 day moving average is $62.44 and its 200-day moving average is $72.69. The company has a market cap of $2.85 billion, a P/E ratio of 13.94, a PEG ratio of 1.93 and a beta of 0.41. The company has a current ratio of 4.38, a quick ratio of 2.99 and a debt-to-equity ratio of 0.55.

Prestige Consumer Healthcare (NYSE:PBH) last released its quarterly earnings data on Thursday, November 6th. The company reported $1.07 earnings per share for the quarter, beating analysts’ consensus estimates of $0.97 by $0.10. The business had revenue of $274.11 million during the quarter, compared to analyst estimates of $257.14 million. Prestige Consumer Healthcare had a net margin of 19.02% and a return on equity of 12.69%. Prestige Consumer Healthcare’s revenue was down 3.4% compared to the same quarter last year. During the same period last year, the business earned $1.09 EPS. Prestige Consumer Healthcare has set its FY 2026 guidance at 4.540-4.580 EPS. Research analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current fiscal year.

Institutional Trading of Prestige Consumer Healthcare

Institutional investors and hedge funds have recently modified their holdings of the business. Intech Investment Management LLC lifted its holdings in Prestige Consumer Healthcare by 18.9% in the first quarter. Intech Investment Management LLC now owns 27,307 shares of the company’s stock worth $2,348,000 after purchasing an additional 4,343 shares during the period. XTX Topco Ltd boosted its holdings in Prestige Consumer Healthcare by 354.0% during the first quarter. XTX Topco Ltd now owns 22,778 shares of the company’s stock worth $1,958,000 after buying an additional 17,761 shares during the last quarter. Voya Investment Management LLC lifted its stake in Prestige Consumer Healthcare by 19.5% in the 1st quarter. Voya Investment Management LLC now owns 41,717 shares of the company’s stock valued at $3,586,000 after acquiring an additional 6,798 shares in the last quarter. Keystone Wealth Services LLC acquired a new stake in Prestige Consumer Healthcare during the 2nd quarter valued at $315,000. Finally, Envestnet Asset Management Inc. raised its stake in Prestige Consumer Healthcare by 6.4% in the first quarter. Envestnet Asset Management Inc. now owns 180,802 shares of the company’s stock valued at $15,544,000 after purchasing an additional 10,876 shares in the last quarter. Institutional investors own 99.95% of the company’s stock.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.